These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17438515)

  • 1. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2007; 14(3 Pt 1):373-84. PubMed ID: 17438515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen effects on arteries vary with stage of reproductive life and extent of subclinical atherosclerosis progression.
    Clarkson TB
    Menopause; 2018 Nov; 25(11):1262-1274. PubMed ID: 30358722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
    Hulley S; Grady D; Bush T; Furberg C; Herrington D; Riggs B; Vittinghoff E
    JAMA; 1998 Aug; 280(7):605-13. PubMed ID: 9718051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of oral hormonal therapies and review of conjugated estrogens/bazedoxifene for the management of menopausal symptoms.
    Parish SJ; Gillespie JA
    Postgrad Med; 2017 Apr; 129(3):340-351. PubMed ID: 28132583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary heart disease of females: lessons learned from nonhuman primates.
    Clarkson TB; Mehaffey MH
    Am J Primatol; 2009 Sep; 71(9):785-93. PubMed ID: 19382155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and the association with coronary heart disease and overall mortality: clinical application of the timing hypothesis.
    Hodis HN; Mack WJ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():68-75. PubMed ID: 23851166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen status correlates with the calcium content of coronary atherosclerotic plaques in women.
    Christian RC; Harrington S; Edwards WD; Oberg AL; Fitzpatrick LA
    J Clin Endocrinol Metab; 2002 Mar; 87(3):1062-7. PubMed ID: 11889163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women.
    Christian RC; Liu PY; Harrington S; Ruan M; Miller VM; Fitzpatrick LA
    J Clin Endocrinol Metab; 2006 Jul; 91(7):2713-20. PubMed ID: 16608893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
    Rossouw JE; Anderson GL; Prentice RL; LaCroix AZ; Kooperberg C; Stefanick ML; Jackson RD; Beresford SA; Howard BV; Johnson KC; Kotchen JM; Ockene J;
    JAMA; 2002 Jul; 288(3):321-33. PubMed ID: 12117397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy in clinical cardiology.
    Bittner V
    Cardiol Rev; 2000; 8(1):57-64. PubMed ID: 11174874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL; Limacher M; Assaf AR; Bassford T; Beresford SA; Black H; Bonds D; Brunner R; Brzyski R; Caan B; Chlebowski R; Curb D; Gass M; Hays J; Heiss G; Hendrix S; Howard BV; Hsia J; Hubbell A; Jackson R; Johnson KC; Judd H; Kotchen JM; Kuller L; LaCroix AZ; Lane D; Langer RD; Lasser N; Lewis CE; Manson J; Margolis K; Ockene J; O'Sullivan MJ; Phillips L; Prentice RL; Ritenbaugh C; Robbins J; Rossouw JE; Sarto G; Stefanick ML; Van Horn L; Wactawski-Wende J; Wallace R; Wassertheil-Smoller S;
    JAMA; 2004 Apr; 291(14):1701-12. PubMed ID: 15082697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women.
    Col NF; Pauker SG; Goldberg RJ; Eckman MH; Orr RK; Ross EM; Wong JB
    Arch Intern Med; 1999 Jul; 159(13):1458-66. PubMed ID: 10399897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen replacement therapy and the prevention of coronary heart disease in postmenopausal women.
    Contreras I; Parra D
    Am J Health Syst Pharm; 2000 Nov; 57(21):1963-8; quiz 1969-71. PubMed ID: 11094650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
    Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
    JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events after menopause.
    Shlipak MG; Simon JA; Vittinghoff E; Lin F; Barrett-Connor E; Knopp RH; Levy RI; Hulley SB
    JAMA; 2000 Apr; 283(14):1845-52. PubMed ID: 10770146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogen treatment on arterial wall structure and function.
    Clarkson TB; Anthony MS; Klein KP
    Drugs; 1994; 47 Suppl 2():42-51. PubMed ID: 7517833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Women's Health Initiative trial and related studies: 10 years later: a clinician's view.
    Gurney EP; Nachtigall MJ; Nachtigall LE; Naftolin F
    J Steroid Biochem Mol Biol; 2014 Jul; 142():4-11. PubMed ID: 24172877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy: new questions and the case for new clinical trials.
    Manson JE; Bassuk SS; Harman SM; Brinton EA; Cedars MI; Lobo R; Merriam GR; Miller VM; Naftolin F; Santoro N
    Menopause; 2006; 13(1):139-47. PubMed ID: 16607110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.